EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Exercise training improves metabolic and circulatory function in COPD patients with NAFLD: evidence from clinical and molecular profiling

Training verbessert metabolische und Kreislauffunktion bei COPD-Patient:innen mit NAFLD: Evidenz aus klinischem und molekularem Profiling

Yi-Cai Qian, Xiaoxiang Liu, Panpan Liu, ShuYing Jia, Yi Ding, Cuiling Zhu, Jing He

Frontiers in Medicine · 29.08.2025 · 12

DOI: 10.3389/fmed.2025.1660072 ↗

Auf einen Blick

In einer Pilotstudie verbesserte ein 12-wöchiges Trainingsprogramm bei COPD-Patient:innen beide Gruppen. Bei COPD mit NAFLD zeigten sich tendenziell stärkere Verbesserungen der Kreislauffunktion und des respiratorischen Stoffwechsels.

Fragestellung

Welchen Effekt hat ein 12-wöchiges Trainingsprogramm bei COPD-Patient:innen mit und ohne NAFLD auf Funktion und molekulare Marker?

Methode

Pilotstudie: COPD-Patient:innen mit Einteilung nach NAFLD-Status; 12-wöchiges Trainingsprogramm; Beurteilung von Lungenfunktion, kardiopulmonalem Belastungstest, ELISA, PCR und Transkriptomik.

Ergebnisse

In beiden Gruppen traten günstige Anpassungen auf. Bei COPD+NAFLD zeigte sich ein stärkerer Trend zur Verbesserung von Kreislauffunktion und respiratorischer Stoffwechselrate; der Unterschied war nicht signifikant (p > 0,05). Nach dem Training war der antiinflammatorische Shift bei COPD+NAFLD ausgeprägter.

Einschränkungen

Die Unterschiede zwischen den Gruppen erreichten keine statistische Signifikanz.

Schlussfolgerung der Autor:innen

Die vorläufigen Befunde sprechen dafür, dass Training bei COPD mit NAFLD besondere Vorteile für Stoffwechseleffizienz und Kreislauffunktion haben könnte. EGR1 könnte ein Biomarker für die Trainingsantwort sein.

Kernaussagen

  • 12-wöchiges Training führte in beiden Gruppen zu günstigen Anpassungen
  • COPD+NAFLD zeigte einen stärkeren Trend zur Verbesserung von Kreislauffunktion und Stoffwechsel
  • EGR1 wurde als mögliches Hub-Gen/Biomarker der Trainingsantwort identifiziert

Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Medicine, online erschienen am 29.08.2025. Verfasst von Yi-Cai Qian und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Anhui Zhongke Gengjiu Hospital, Hefei, China. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

Auf einen BlickAbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Non-alcoholic fatty liver disease (NAFLD) and chronic obstructive pulmonary disease (COPD) are frequently comorbid, affecting up to 41% of COPD patients. Both conditions exhibit significant metabolic and inflammatory dysregulation. While exercise training improves individual disease outcomes by reducing systemic inflammation, its therapeutic effects and underlying mechanisms in COPD patients with NAFLD comorbidity are not well understood. This pilot trial aimed to evaluate the impact of exercise on COPD patients with and without NAFLD, identifying potential biomarkers of exercise-induced regulation.

Methods

COPD patients, categorized by NAFLD status, participated in a 12-week exercise training program. Rehabilitation efficacy was assessed based on lung function and cardiopulmonary exercise test. Metabolic improvements were tested by measuring inflammatory factors, anti-inflammatory factors, etc., using ELISA and PCR methods. Transcriptomic analysis was performed on patients’ samples before and after exercise, integrating external datasets to identify key molecular changes affecting both liver function and systemic inflammation. Hub genes were selected through bioinformatics analysis and validated for their expression in patient samples.

Results

Exercise training elicited beneficial adaptations in both groups. Notably, the COPD with NAFLD group exhibited a greater improvement trend in circulatory function and respiratory metabolic rate compared to COPD-only patients. However, the difference did not reach statistical significance ( p > 0.05). Furthermore, post-exercise analysis indicated a more pronounced anti-inflammatory shift in the COPD+NAFLD group, with broader reductions in pro-inflammatory cytokines and upregulation of IL-4 compared to the COPD-only group. Transcriptomic analysis integrated with public datasets identified Early Growth Response 1 (EGR1) as a key exercise-response hub gene; its expression was downregulated in the COPD+NAFLD group after exercise but upregulated in the COPD-only group, correlating positively with M2 macrophages (derived from liver single-cell transcriptomic data) and negatively with monocytes.

Conclusion

Our preliminary findings suggest that exercise training may offer unique benefits for patients with comorbid COPD and NAFLD, particularly by enhancing metabolic efficiency and circulatory function. EGR1 may serve as a potential biomarker for exercise responsiveness in this population, reflecting underlying immunomodulatory mechanisms. This insight may also aid in distinguishing COPD subtypes and tailoring exercise-based therapeutic strategies.

Schlagwörter

Stichwörter der Autor:innen

EGR1chronic obstructive lung diseaseexercise trainingnon-alcoholic fatty liver diseasetranscriptomics

Autor:innen und Institutionen

  • Department of Neurosurgery, Anhui Zhongke Gengjiu Hospital, Hefei, China.
  • Department of Radiology, First People's Hospital of Changde, Changde, China.
  • Department of Pulmonary and Critical Care Medicine, Shanghai Pudong New Area Gongli Hospital, Shanghai, China.
  • Department of Pulmonary and Critical Care Medicine, The Second Hospital of Jilin University, Changchun, China.
  • Department of Endocrinology and Metabolism, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, China.
  • Department of Endocrinology, The Third People's Hospital of Hefei, Hefei Third Clinical College of Anhui Medical University, Hefei, China.

Zitieren

APA

Qian, Y. C., Liu, X., Liu, P., Jia, S., Ding, Y., Zhu, C., & He, J. (2025). Exercise training improves metabolic and circulatory function in COPD patients with NAFLD: evidence from clinical and molecular profiling. Frontiers in Medicine, 12. https://doi.org/10.3389/fmed.2025.1660072

Vancouver

Qian YC, Liu X, Liu P, Jia S, Ding Y, Zhu C, et al. Exercise training improves metabolic and circulatory function in COPD patients with NAFLD: evidence from clinical and molecular profiling. Frontiers in Medicine. 2025;12. doi:10.3389/fmed.2025.1660072

BibTeX
@article{Qian2025,
  author = {Qian, Yi-Cai and Liu, Xiaoxiang and Liu, Panpan and Jia, ShuYing and Ding, Yi and Zhu, Cuiling and He, Jing},
  title = {Exercise training improves metabolic and circulatory function in COPD patients with NAFLD: evidence from clinical and molecular profiling},
  journal = {Frontiers in Medicine},
  year = {2025},
  volume = {12},
  doi = {10.3389/fmed.2025.1660072}
}
Kostenlos starten →